Literature DB >> 26768035

Recommendations for excision following core needle biopsy of the breast: a contemporary evaluation of the literature.

Benjamin C Calhoun1, Laura C Collins2.   

Abstract

Pathologists frequently encounter non-malignant histological findings in percutaneous core needle biopsies (CNBs). Standards for the management of patients with lesions such as atypical ductal hyperplasia, atypical lobular hyperplasia, and lobular carcinoma in situ, as well as other benign lesions, are not well defined, and recommendations for surgical biopsy or continued clinical and radiological follow-up are inconsistent. The frequency with which these lesions are 'upgraded' to carcinoma in excision specimens is widely variable in the literature. Many CNB studies lack careful radiological-pathological correlation, clear criteria for excision, and clinical follow-up for patients on whom excision was not performed. This review of the recent literature emphasizes studies with radiological-pathological correlation, with the goal of developing a contemporary, evidence-based approach to the management of non-malignant lesions of the breast diagnosed on CNB. The data supporting an emerging consensus on which lesions may not require excision are highlighted. The management of non-malignant lesions diagnosed on magnetic resonance imaging-guided CNB is also discussed.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  atypical hyperplasia; benign breast disease; core needle biopsy; upgrade rate

Mesh:

Year:  2016        PMID: 26768035     DOI: 10.1111/his.12852

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  11 in total

Review 1.  Benign Breast Disease in Women.

Authors:  Angrit Stachs; Johannes Stubert; Toralf Reimer; Steffi Hartmann
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

2.  Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.

Authors:  Iskender Sinan Genco; Bugra Tugertimur; Qing Chang; Lauren Cassell; Sabina Hajiyeva
Journal:  Virchows Arch       Date:  2019-11-27       Impact factor: 4.064

3.  Lesion characteristics, histopathologic results, and follow-up of breast lesions after MRI-guided biopsy.

Authors:  Füsun Taşkın; Aykut Soyder; Ahmet Tanyeri; Veli Süha Öztürk; Alparslan Ünsal
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

Review 4.  Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.

Authors:  Kelly L Mooney; Lawrence W Bassett; Sophia K Apple
Journal:  Mod Pathol       Date:  2016-08-19       Impact factor: 7.842

5.  Is the outcome at surgery different when flat epithelial atypia and lobular neoplasia are found in association at biopsy?

Authors:  Mona El Khoury; Lilia Maria Sanchez; Lucie Lalonde; Isabelle Trop; Julie David; Benoît Mesurolle
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

6.  Malignancy Rate and Malignancy Risk Assessment in Different Lesions of Uncertain Malignant Potential in the Breast (B3 Lesions): An Analysis of 192 Cases from a Single Institution.

Authors:  Svjetlana Mohrmann; Anna Maier-Bode; Frederic Dietzel; Petra Reinecke; Natalia Krawczyk; Thomas Kaleta; Ulrike Kreimer; Gerald Antoch; Tanja N Fehm; Katrin Sabine Roth
Journal:  Breast Care (Basel)       Date:  2021-07-01       Impact factor: 2.268

Review 7.  Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?

Authors:  Marco Lucioni; Chiara Rossi; Pascal Lomoro; Francesco Ballati; Marianna Fanizza; Alberta Ferrari; Carlos A Garcia-Etienne; Emanuela Boveri; Giulia Meloni; Maria Grazia Sommaruga; Elisa Ferraris; Angioletta Lasagna; Elisabetta Bonzano; Marco Paulli; Adele Sgarella; Giuseppe Di Giulio
Journal:  Eur Radiol       Date:  2020-08-20       Impact factor: 5.315

8.  Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.

Authors:  Christiane Richter-Ehrenstein; Katharina Maak; Sonja Röger; Tilman Ehrenstein
Journal:  BMC Cancer       Date:  2018-08-16       Impact factor: 4.430

9.  Breast lesions with atypia in percutaneous biopsies, managed with surgery in the last 10 years.

Authors:  Mitzy Carrillo; Gregorio Maturana; Cristóbal Maiz; Diego Romero; Francisco Domínguez; David Oddó; Alejandra Villarroel; Dravna Razmilic; María Elena Navarro; Augusto León; César Sánchez; Mauricio Camus
Journal:  Ecancermedicalscience       Date:  2019-04-11

Review 10.  Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.

Authors:  Tanjina Kader; Prue Hill; Emad A Rakha; Ian G Campbell; Kylie L Gorringe
Journal:  Breast Cancer Res       Date:  2018-05-02       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.